Waters Corp (WAT)
350.95
+14.53
(+4.32%)
USD |
NYSE |
May 10, 16:00
350.95
0.00 (0.00%)
After-Hours: 18:34
Waters Enterprise Value: 21.67B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 21.67B |
| May 08, 2024 | 20.93B |
| May 07, 2024 | 21.06B |
| May 06, 2024 | 20.69B |
| May 03, 2024 | 20.77B |
| May 02, 2024 | 20.43B |
| May 01, 2024 | 20.45B |
| April 30, 2024 | 20.05B |
| April 29, 2024 | 20.41B |
| April 26, 2024 | 20.18B |
| April 25, 2024 | 20.01B |
| April 24, 2024 | 20.12B |
| April 23, 2024 | 20.30B |
| April 22, 2024 | 19.46B |
| April 19, 2024 | 19.28B |
| April 18, 2024 | 19.17B |
| April 17, 2024 | 19.76B |
| April 16, 2024 | 20.32B |
| April 15, 2024 | 20.67B |
| April 12, 2024 | 20.85B |
| April 11, 2024 | 21.76B |
| April 10, 2024 | 21.71B |
| April 09, 2024 | 22.18B |
| April 08, 2024 | 21.83B |
| April 05, 2024 | 21.64B |
| Date | Value |
|---|---|
| April 04, 2024 | 21.54B |
| April 03, 2024 | 21.95B |
| April 02, 2024 | 21.87B |
| April 01, 2024 | 22.15B |
| March 31, 2024 | 22.13B |
| March 28, 2024 | 22.38B |
| March 27, 2024 | 22.43B |
| March 26, 2024 | 22.01B |
| March 25, 2024 | 22.29B |
| March 22, 2024 | 22.52B |
| March 21, 2024 | 22.83B |
| March 20, 2024 | 22.58B |
| March 19, 2024 | 22.62B |
| March 18, 2024 | 22.52B |
| March 15, 2024 | 22.85B |
| March 14, 2024 | 22.30B |
| March 13, 2024 | 22.78B |
| March 12, 2024 | 22.88B |
| March 11, 2024 | 22.91B |
| March 08, 2024 | 23.03B |
| March 07, 2024 | 23.33B |
| March 06, 2024 | 22.62B |
| March 05, 2024 | 22.29B |
| March 04, 2024 | 22.49B |
| March 01, 2024 | 22.45B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
11.40B
Minimum
Mar 23 2020
27.00B
Maximum
Sep 08 2021
18.36B
Average
18.64B
Median
Enterprise Value Benchmarks
| Exact Sciences Corp | 11.71B |
| Illumina Inc | 18.12B |
| Mettler-Toledo International Inc | 29.73B |
| Natera Inc | 11.17B |
| Castle Biosciences Inc | 445.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 102.20M |
| Revenue (Quarterly) | 636.84M |
| Total Expenses (Quarterly) | 492.75M |
| EPS Diluted (Quarterly) | 1.72 |
| Gross Profit Margin (Quarterly) | 58.89% |
| Profit Margin (Quarterly) | 16.05% |
| Earnings Yield | 2.90% |
| Operating Earnings Yield | 3.79% |
| Normalized Earnings Yield | 2.947 |